Search Results

There are 3445989 results for: content related to: Commentary: IBD combination therapy - adalimumab plus immunosuppressants

  1. You have free access to this content
    Does co-treatment with immunosuppressors improve outcome in patients with Crohn's disease treated with adalimumab?

    Alimentary Pharmacology & Therapeutics

    Volume 36, Issue 11-12, December 2012, Pages: 1040–1048, C. Reenaers, E. Louis, J. Belaiche, L. Seidel, S. Keshav and S. Travis

    Version of Record online : 14 OCT 2012, DOI: 10.1111/apt.12076

  2. You have free access to this content
    One-year maintenance outcomes among patients with moderately-to-severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2

    Alimentary Pharmacology & Therapeutics

    Volume 37, Issue 2, January 2013, Pages: 204–213, W. J. Sandborn, J.-F. Colombel, G. D'Haens, G. Van Assche, D. Wolf, M. Kron, A. Lazar, A. M. Robinson, M. Yang, J. D. Chao and R. Thakkar

    Version of Record online : 23 NOV 2012, DOI: 10.1111/apt.12145

  3. You have free access to this content
    Comparison of long-term clinical outcome with etanercept treatment and adalimumab treatment of rheumatoid arthritis with respect to immunogenicity

    Arthritis & Rheumatism

    Volume 64, Issue 12, December 2012, Pages: 3850–3855, Charlotte L. Krieckaert, Anna Jamnitski, Michael T. Nurmohamed, Piet J. Kostense, Maarten Boers and Gertjan Wolbink

    Version of Record online : 28 NOV 2012, DOI: 10.1002/art.34680

  4. You have free access to this content
    The decline of anti-drug antibody titres after discontinuation of anti-TNFs: implications for predicting re-induction outcome in IBD

    Alimentary Pharmacology & Therapeutics

    Volume 35, Issue 6, March 2012, Pages: 714–722, S. Ben-Horin, Y. Mazor, H. Yanai, Y. Ron, U. Kopylov, M. Yavzori, O. Picard, E. Fudim, Y. Maor, A. Lahat, D. Coscas, R. Eliakim, I. Dotan and Y. Chowers

    Version of Record online : 30 JAN 2012, DOI: 10.1111/j.1365-2036.2012.04997.x

  5. A protein-stabilizing technology for enhanced antibody stability and antibody-binding profiles in a microchip array

    Biotechnology Journal

    Volume 7, Issue 8, August 2012, Pages: 1002–1007, Prof. Dr. Martin Scholz and Dr. Angelika Lüking

    Version of Record online : 27 APR 2012, DOI: 10.1002/biot.201100494

  6. You have free access to this content
    Predictors of relapse in patients with Crohn's disease in remission after 1 year of biological therapy

    Alimentary Pharmacology & Therapeutics

    Volume 37, Issue 2, January 2013, Pages: 225–233, T. Molnár, P. L. Lakatos, K. Farkas, F. Nagy, Z. Szepes, P. Miheller, G. Horváth, M. Papp, K. Palatka, T. Nyári, A. Bálint, K. Lőrinczy and T. Wittmann

    Version of Record online : 26 NOV 2012, DOI: 10.1111/apt.12160

  7. You have free access to this content
    Review article: description and management of fatigue in inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 37, Issue 5, March 2013, Pages: 505–516, W. Czuber-Dochan, E. Ream and C. Norton

    Version of Record online : 13 JAN 2013, DOI: 10.1111/apt.12205

  8. You have free access to this content
    NICE clinical guideline (CG152): the management of Crohn's disease in adults, children and young people

    Alimentary Pharmacology & Therapeutics

    Volume 37, Issue 2, January 2013, Pages: 195–203, J. F. Mayberry, A. Lobo, A. C. Ford and A. Thomas, Guideline Development Group

    Version of Record online : 14 NOV 2012, DOI: 10.1111/apt.12102

  9. You have free access to this content
    Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 37, Issue 4, February 2013, Pages: 420–429, M. D. Long, C. Martin, R. S. Sandler and M. D. Kappelman

    Version of Record online : 13 DEC 2012, DOI: 10.1111/apt.12182

  10. You have free access to this content
    Systematic review: antibodies and anti-TNF-α levels in inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 35, Issue 9, May 2012, Pages: 971–986, M. Chaparro, I. Guerra, P. Muñoz-Linares and J. P. Gisbert

    Version of Record online : 22 MAR 2012, DOI: 10.1111/j.1365-2036.2012.05057.x

  11. You have full text access to this OnlineOpen article
    Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study

    Arthritis & Rheumatism

    Volume 65, Issue 1, January 2013, Pages: 28–38, Michael E. Weinblatt, Michael Schiff, Robert Valente, Désirée van der Heijde, Gustavo Citera, Cathy Zhao, Michael Maldonado and Roy Fleischmann

    Version of Record online : 27 DEC 2012, DOI: 10.1002/art.37711

  12. Emerging data on the use of anti-tumor necrosis factor-alpha medications in pregnancy

    Birth Defects Research Part A: Clinical and Molecular Teratology

    Volume 94, Issue 8, August 2012, Pages: 607–611, Christina D. Chambers and Diana L. Johnson

    Version of Record online : 11 JUL 2012, DOI: 10.1002/bdra.23033

  13. You have free access to this content
    Review article: a decision-making algorithm for the management of pregnancy in the inflammatory bowel disease patient

    Alimentary Pharmacology & Therapeutics

    Volume 35, Issue 5, March 2012, Pages: 501–515, F. M. Habal and V. W. Huang

    Version of Record online : 5 JAN 2012, DOI: 10.1111/j.1365-2036.2011.04967.x

  14. You have free access to this content
    Anti-tumour necrosis factor treatment of inflammatory bowel disease in liver transplant recipients

    Alimentary Pharmacology & Therapeutics

    Volume 36, Issue 6, September 2012, Pages: 569–574, A. B. Mohabbat, W. J. Sandborn, E. V. Loftus Jr, R. H. Wiesner and D. H. Bruining

    Version of Record online : 10 JUL 2012, DOI: 10.1111/j.1365-2036.2012.05217.x

  15. You have free access to this content
    Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays

    Alimentary Pharmacology & Therapeutics

    Volume 36, Issue 8, October 2012, Pages: 765–771, N. Vande Casteele, D. J. Buurman, M. G. G. Sturkenboom, J. H. Kleibeuker, S. Vermeire, T. Rispens, D. van der Kleij, A. Gils and G. Dijkstra

    Version of Record online : 28 AUG 2012, DOI: 10.1111/apt.12030

  16. You have free access to this content
    Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with Crohn's disease – a nationwide cohort study

    Alimentary Pharmacology & Therapeutics

    Volume 37, Issue 2, January 2013, Pages: 214–224, B. M. Nørgård, J. Nielsen, N. Qvist, K. O. Gradel, O. B. Schaffalitzky de Muckadell and J. Kjeldsen

    Version of Record online : 28 NOV 2012, DOI: 10.1111/apt.12159

  17. You have free access to this content
    Review article: non-malignant haematological complications of anti-tumour necrosis factor alpha therapy

    Alimentary Pharmacology & Therapeutics

    Volume 36, Issue 4, August 2012, Pages: 312–323, T. Bessissow, M. Renard, I. Hoffman, S. Vermeire, P. Rutgeerts and G. Van Assche

    Version of Record online : 24 JUN 2012, DOI: 10.1111/j.1365-2036.2012.05189.x

  18. You have free access to this content
    Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti–tumor necrosis factor antibody therapy

    Arthritis & Rheumatism

    Volume 64, Issue 10, October 2012, Pages: 3129–3138, Jenny L. McGovern, Dao X. Nguyen, Clare A. Notley, Claudia Mauri, David A. Isenberg and Michael R. Ehrenstein

    Version of Record online : 27 SEP 2012, DOI: 10.1002/art.34565

  19. You have free access to this content
    Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 38, Issue 9, November 2013, Pages: 1002–1024, G. W. Moran, A. W. K. Lim, J. L. Bailey, M.-F. Dubeau, Y. Leung, S. M. Devlin, K. Novak, G. G. Kaplan, M. Iacucci, C. Seow, L. Martin, R. Panaccione and S. Ghosh

    Version of Record online : 25 SEP 2013, DOI: 10.1111/apt.12491

  20. You have free access to this content
    The safety and efficacy of antitumour necrosis factor-alpha therapy for inflammatory bowel disease in patients post liver transplantation: a case series

    Alimentary Pharmacology & Therapeutics

    Volume 36, Issue 2, July 2012, Pages: 159–165, A. Sandhu, T. Alameel, C. H. Dale, M. Levstik and N. Chande

    Version of Record online : 23 MAY 2012, DOI: 10.1111/j.1365-2036.2012.05141.x